Desoxyn is the brand name for methamphetamine hydrochloride, a potent central nervous system (CNS) stimulant available as an oral tablet. Because it is a Schedule II controlled substance, it carries a high potential for misuse, dependency, and addiction, and its use is strictly regulated ADHD: It is FDA-approved to treat Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients aged 6 years and older, as well as adults, typically when other treatments have not been effective Obesity (Short-Term): It is sometimes prescribed as a short-term adjunct for weight loss in adults and older children who have not responded to alternative therapies like diet and exercise Usage: Treatment is individualized based on patient need, and adjustments are managed carefully by a prescribing physician. Timing: It is strongly recommended to avoid taking Desoxyn late in the evening to prevent insomnia Desoxyn carries a Black Box Warning due to its high potential for abuse and severe health risks Serious Risks: Sudden cardiac death, stroke, heart attack, psychiatric reactions (such as psychosis or mania), seizures, and growth suppression in children Common Side Effects: Elevated blood pressure, rapid heart rate, tremors, insomnia, dizziness, dry mouth, decreased appetite, and weight loss. Key Contraindications: It must never be used by individuals with severe heart disease, advanced hardening of the arteries, moderate-to-severe high blood pressure, glaucoma, hyperthyroidism, or a history of substance abuse. It is also strictly contraindicated within a specific timeframe of taking Monoamine Oxidase Inhibitors (MAOIs)